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Introduction
Several recent studies have shown that the unfavourable prognosis for induction of labour signalled by an unripe cervix may be much improved by vaginal administration of prostaglandin E2 in simple gels and pessaries and that labour is often promoted without the need for formal induction.1-4 This method is increasingly favoured and would be still more widely used if a commercial product was available, but hitherto a prostaglandin E2 preparation with adequate long-term stability has not been developed. Additionally, experience suggests that a sustained-release vaginal preparation would be advantageous.
Initial laboratory studies incorporating prostaglandins in a water-swellable, cross-linked polymer (hydrogel) indicated that such a system should exhibit stability and provide sustained release of prostaglandin over prolonged intervals. 5 We report on our early clinical experience of using a prostaglandin E2 polymer vaginal pessary in the induction of labour.
In-vivo studies
We treated 66 patients (41 primigravidas, 25 multigravidas) requiring induction of labour for medical or obstetric reasons at 38-42 weeks' gestation. During the study period the dose of prostaglandin E2 incorporated in the pessary varied, depending on the formulation of the polymer and its in-vitro release profile. In most cases we used a pessary that in vitro released about 75% of its content over 12 hours; the incorporated dose of prostaglandin E2 was 10 mg for primigravidas and 5 mg for multigravidas. Some patients who presented early in the trial, when a formulation with a less satisfactory profile was used, received a larger dose (up to 20 mg in primigravidas).
Usually overnight and about 12 hours before induction was planned, the pessary was inserted in the vaginal vault after cervical assessment with a modified Bishop score.6 The patient remained recumbent for 15 minutes after insertion, and maternal pulse, blood pressure, uterine activity, and fetal heart rate were observed regularly for four to five hours and for longer if labour became established. Internal tocographic records showed that treatment provoked a pattern of frequent contractions (at one-to three-minute intervals) of low amplitude (less than 40 mm Hg) and causing little discomfort, starting after one to two hours: the contractions persisted for four to six hours and then either waned or were augmented as labour became established. The next day, if labour was not established, formal induction was performed by amniotomy followed if necessary by intravenous oxytocin. The pessary was removed when labour was established or at the time of amniotomy. The labour was managed by the duty delivery-suite staff.
Results
The establishment of labour after treatment depended on parity and was related to the initial cervical score ( There were no gastrointestinal side effects attributable to the prostaglandin treatment and no evidence of fetal compromise as judged by the absence of low one-minute Apgar scores (less than 5).
Discussion
There is now considerable evidence confirming that prostaglandin E2 administered vaginally before planned induction of labour effectively ripens the unfavourable cervix, often obviates the need for formal induction, and improves the prognosis of labour. When the cervix is ripe labour is established in most patients and greater benefits accrue; augmentation with oxytocin and epidural analgesia are needed less often, the incidence of spontaneous vaginal delivery is increased, and caesarean section is rarely required.
These beneficial effects were first achieved by administering prostaglandin E2 in a viscous cellulose gel,1 2 while more recently glyceride-based (Witepsol) pessaries have been used.3 Unfortunately the relative instability of these simple formulations of prostaglandin E2 has deterred commercial production, while an additional disadvantage is that dissolution, and presumably absorption, of the gels and pessaries occur quickly (within two to four hours) with the risk, in some multigravidas, of unduly rapid progress in labour.
In this limited trial a prostaglandin E2 polymer pessary gave encouraging results in the induction of labour, comparable to those obtained with the alternative vaginal preparations, while additionally possessing the important advantages of controlled sustained release of the prostaglandin and long-term stability. The ability to tailor the pessary to provide a desired release profile-a relatively short release when induction of labour is simple and a more prolonged action for ripening the unfavourable cervix-offers the prospect of improved results as experience increases. Moreover, the delivery system may be adapted to other roles in reproduction: by providing sustained release of promising but hitherto unstable prostaglandin E analogues it has obvious potential in the termination of early pregnancy and induction of menstruation.
The method is simple and convenient, with a high degree of patient acceptability, and this initial study indicates that the sustained release of prostaglandin E2 provided by this new polymer pessary is an important contribution in the development of non-invasive methods of inducing labour.
Appendix IN-VITRO STUDIES
Polyethylene oxide cross-linked polymers from formulations 10 mg prostaglandin E, uniformly dispersed through the matrix of moderate-molecular-weight polyethylene glycol, 1,2,6-hexane and stored at 4GC until required. In addition to the pessaries triol, and pure diphenyl methane diisocyanate are hydrophilic for clinical use, identical pessaries containing 'H-prostaglanand, even when swollcn to several times their original dry din E. were prepared and their in-vitro release profile in weight, tough and rubbery. The polymers prepared for this phosphate buffer at 37 C studied as a guide to clinical study have an equilibrium swelling in water at 37'C of 400-500 performance. parts per hundred of initial weight.
Experiment showed that compared with cylindrical pessaries
The reactants were mixed in stoichiometric proportions at a pcssary of rectangular slab design (32 10 2 5 mm) gave an 80'CandpouredintoheatedTeflonorhigh-densitypolyethylene improved rate of release of prostaglandin E,. This dry dcvice, moulds to cure at 95'C for four hours. After cooling the as it swells in vivo or in vitro with absorption of water and polyethylene oxide block was cut to the dimensions requirced diffusion of prostaglandin E, across the polymer-fluid interface, for the pessaries. Residual material of low molecular weight shows a reasonably constant rate of release (zero order) over a was extracted in water and the samples vacuum dried at room considerable period before changing to a lower value (figure).
temperature. When tested in cell culture system L929 with Its half life is directly proportional to the square of the thickness mouse fibroblasts the material showed no toxic response. Use of the device, makng it possible to calculate the optimum of the median lethal dose in mice and subcutancous implantation thickness for a desired half life and facilitating adjustments in of the ground material in rats also failed to produce any toxic the light of clinical experience. The details of thest devices, or abnormal response.
which offer an attractive and novel way of providing relatively Prostaglandin E, was incorporated in the steralised samples constant profiles of conained drug release, will be published by swelling them in a 1/1 w/w chloroform/ethanol solution of elsewhere. prostaglandin E,, the concentration of the solution being Methodology for extracting and assaying cold prostaglandin calculated from the required prostaglandin content of the E, in the pessary has also been developed, enabling measutepessary (usually 10 mg) and the equilibrium swelling of the ments of the prostaglandin E, content before and after use to be polymer in the solution. The fully swollen pessaries were coffelated with clinical events. Other studies have shown the vacuum dried to constant weight at anbient temperature, stability of the pessary, with no evidence of loss or degradation yielding dry prostaglandin E,/polyethylene oxide pessaries with of prostaglandin E, after storage at 4cC for over a year. In-vitro release of prostagldin E, polymer pesstat, dry tite 25 *10 to32 mm, ia phosphate bffer at 37C. Half life as 6-8 hours.
ONE HUNDRED YEARS AGO
Mr Turnbull, in crossing the Atlantic on board the steamer Britannia, writes: "... The sea was lumpy, and during the night the greater number of the passengers were paying their devotions to the sea-fishes. My fellow-passengers in the adjoining state-room soon excited my sympathies. They consisted of a lady about twenty-five years, a young girl of three years and a half, and a maid-servant. The latter was the most noisy by loud efforts and groanings; then followed the lady and girl, but in a quieter manner. I gave the husband three nitro-glycerine lozenges, one each for the adults, and a quarter for the little girl. Soon after, the husband reported the little girl quite better and playing on the floor, with no return; a decided improvement of the wife's condition, and even an amelioration of the noisy demonstrations of the maid. In the little girl, the improvement was entirely permanent; while the other two did vomit after, but soon after became quite comfortable. The next case was my associate in the same state-room, who stated he was always sick crossing. He was young-twenty-six years-robust, weighing two hundred pounds, with a most ravenous appetite. He took one lozenge; but in a few seconds after he stated he vomited it, and would not repeat the dose. Soon after, I gave him fifteen drops of aromatic spirit of ammonia, and from that time he had no return. The fifth case was a celebrated western bishop, who came upon deck and stated he felt nauseated and badly; but he thought by force of will he would not be sick. I told him of the remedy; he desired to take it. I gave him one lozenge; and soon after he told me it gave him such relief, that he was able to go down to the saloon and eat his breakfast; he with two others being all out of ten that were able to do so at our table during the stormy weather. To two adults also I administered the remedy; but in neither case was it of any value, not being retained." These nitro-glycerine tablets are supplied by Mr Martindale, chemist, New Gavendish Street. (British Medical J7ournal, 1880.)
